glp-1 inhibitor A Closer Look at the Dermatological Profile of Agonists GLP-1 and Anesthesia: Considerations and
Description
An elevated resting heart rate can increase long-term cardiovascular risk, and regulators need robust data confirming that the metabolic benefits outweigh this potential downside

The key distinction is regulatory, not pharmacological
GLP-1s havent been proven or approved to treat RA

Disclaimer This article is for educational purposes only and is not a substitute for medical advice

[DOI] [PubMed] [Google Scholar] 51.Facciorusso A., Ramai D., Gkolfakis P., Khan S.R., Papanikolaou I.S., Triantafyllou K., Tringali A., Chandan S., Mohan B.P., Adler D.G
